Kausik Ray, MD: Inclisiran for ASCVD
The ORION-11 principal investigator highlights new LDL-C reduction findings and teases future research for the siRNA-targeting drug.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.